Strong humoral response elicited by a DNA vaccine targeting gastrin-releasing peptide with optimized adjuvants inhibits murine prostate carcinoma growth in vivo

Endocrine-Related Cancer

Volumn 16, Issue 4, 2009, Pages 1171-1184

  Lu, Yong ^a,b   Mekoo, Didier J L ^a   Ouyang, Kedong ^a   Hu, Xiangbing ^a   Liu, Yanhua ^a   Lin, Ming ^a   Jin, Liang ^a   Cao, Rongyue ^a   Li, Taiming ^a   Zhang, Yankai ^a   Fan, Hao ^b   Liu, Jingjing ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Shanghai Yijiu Biomedical Cooperation Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; EPITOPE; GASTRIN RELEASING PEPTIDE VACCINE; HEAT SHOCK PROTEIN 65; HEAT SHOCK PROTEIN 70; HLA DR ANTIGEN; NEUROMEDIN C; PLASMID VECTOR; SIGNAL PEPTIDE; TETANUS TOXOID; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR 183; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE; CANCER ADJUVANT THERAPY; CANCER INHIBITION; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG DESIGN; DRUG EFFICACY; DRUG SPECIFICITY; DRUG TARGETING; HORMONE RESPONSE; HUMORAL IMMUNITY; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PROCESS OPTIMIZATION; PROSTATE CARCINOMA;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BLOTTING, WESTERN; CANCER VACCINES; CELL PROLIFERATION; CHROMATOGRAPHY, AFFINITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASTRIN-RELEASING PEPTIDE; HEAT-SHOCK PROTEINS; IMMUNITY, HUMORAL; IMMUNIZATION; MALARIA VACCINES; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; VACCINES, DNA;

EID: 72549113475     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0058     Document Type: Article

References (40)

1. Agadjanyan MG, Ghochikyan A, Petrushina I, Vasilevko V, Movsesyan N, Mkrtichyan M, Saing T & Cribbs DH 2005 Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide. Journal of Immunology 174 1580-1586.
2. Alexander J, del Guercio MF, Maewal A, Qiao L, Fikes J, Chesnut RW, Paulson J, Bundle DR, DeFrees S & Sette A 2000 Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses. Journal of Immunology 164 1625-1633. (Pubitemid 30067283)
3. Biragyn A, Tani K, Grimm MC, Weeks S & Kwak LW 1999 Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity. Nature Biotechnology 17 253-258.
4. Calarota SA & Weiner DB 2004 Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants. Immunological Reviews 199 84-99.
5. Chaudhry A, Carrasquillo JA, Avis IL, Shuke N, Reynolds JC, Bartholomew R, Larson SM, Cuttitta F, Johnson BE & Mulshine JL 1999 Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer. Clinical Cancer Research 5 3385-3393.
6. Chen CH, Wang TL, Hung CF, Yang Y, Young RA, Pardoll DM & Wu TC 2000 Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Research 60 1035-1042. (Pubitemid 30129542)
7. Clarijs R, Schalkwijk L, Ruiter DJ & de Waal RM 2003 EMAP-II expression is associated with macrophage accumulation in primary uveal melanoma. Investigative Ophthalmology & Visual Science 44 1801-1806. (Pubitemid 36520264)
8. Cornelio DB, Roesler R & Schwartsmann G 2007 Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. Annals of Oncology 18 1457-1466. (Pubitemid 47365477)
9. Cusi MG, Terrosi C, Savellini GG, Di Genova G, Zurbriggen R & Correale P 2004 Efficient delivery of DNA to dendritic cells mediated by influenza virosomes. Vaccine 22 735-739. (Pubitemid 38114904)
10. Donnelly JJ, Ulmer JB, Shiver JW & Liu MA 1997 DNA vaccines. Annual Review of Immunology 15 617-648.
11. Garcia B, Neninger E, de la Torre A, Leonard I, Martinez R, Viada C, Gonzalez G, Mazorra Z, Lage A & Crombet T 2008 Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine. Clinical Cancer Research 14 840-846. (Pubitemid 351231168)
12. Gonzalez G & Lage A 2007 Cancer vaccines for hormone/growth factor immune deprivation: a feasible approach for cancer treatment. Current Cancer Drug Targets 7 229-241. (Pubitemid 46699074)
13. Greenland JR & Letvin NL 2007 Chemical adjuvants for plasmid DNA vaccines. Vaccine 25 3731-3741.
14. Guojun W, Wei G, Kedong O, Yi H, Yanfei X, Qingmei C, Yankai Z, Jie W, Hao F, Taiming L et al. 2008 A novel vaccine targeting gastrin-releasing peptide: efficient inhibition of breast cancer growth in vivo. Endocrine-Related Cancer 15 149-159.
15. Hung CF, Cheng WF, Chai CY, Hsu KF, He L, Ling M & Wu TC 2001 Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen. Journal of Immunology 166 5733-5740. (Pubitemid 32374199)
16. Jin L, Zhu A, Wang Y, Chen Q, Xiong Q, Li J, Sun Y, Li T, Cao R, Wu J et al. 2008 A Th1-recognized peptide P277, when tandemly repeated, enhances a Th2 immune response toward effective vaccines against autoimmune diabetes in nonobese diabetic mice. Journal of Immunology 180 58-63.
17. Kang J, Ishola TA, Baregamian N, Mourot JM, Rychahou PG, Evers BM & Chung DH 2007 Bombesin induces angiogenesis and neuroblastoma growth. Cancer Letters 253 273-281. (Pubitemid 47017542)
18. King CA, Spellerberg MB, Zhu D, Rice J, Sahota SS, Thompsett AR, Hamblin TJ, Radl J & Stevenson FK 1998 DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma. Nature Medicine 4 1281-1286. (Pubitemid 28512109)
19. Klinman DM, Yamshchikov G & Ishigatsubo Y 1997 Contribution of CpG motifs to the immunogenicity of DNA vaccines. Journal of Immunology 158 3635-3639. (Pubitemid 127488716)
20. Kreisle RA & Ershler WB 1988 Investigation of tumor angiogenesis in an id mouse model: role of host-tumor interactions. Journal of the National Cancer Institute 80 849-854. (Pubitemid 18190297)
21. Kumar A, Arora R, Kaur P, Chauhan VS & Sharma P 1992 "Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide. Journal of Immunology 148 1499-1505.
22. Lee YJ, Nagai N, Siar CH, Nakano K, Nagatsuka H, Tsujigiwa H, Roan CH & Gunduz M 2002 Angioarchitecture of primary oral malignant melanomas. Journal of Histochemistry and Cytochemistry 50 1555-1562. (Pubitemid 36024904)
23. Li X, Yang X, Li L, Liu H & Liu J 2006 A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine. Vaccine 24 3321-3331.
24. Miyazaki M, Lamharzi N, Schally AV, Halmos G, Szepeshazi K, Groot K & Cai RZ 1998 Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095. European Journal of Cancer 34 710-717. (Pubitemid 28218949)
25. Moody TW, Jensen RT, Garcia L & Leyton J 2000 Nonpeptide neuromedin B receptor antagonists inhibit the proliferation of C6 cells. European Journal of Pharmacology 409 133-142. (Pubitemid 30947043)
26. Moody TW, Leyton J, Garcia-Marin L & Jensen RT 2003 Nonpeptide gastrin releasing peptide receptor antagonists inhibit the proliferation of lung cancer cells. European Journal of Pharmacology 474 21-29. (Pubitemid 37289142)
27. Moody TW, Mantey SA, Pradhan TK, Schumann M, Nakagawa T, Martinez A, Fuselier J, Coy DH & Jensen RT 2004 Development of high affinity camptothecin-bombesin conjugates that have targeted cytotoxicity for bombesin receptor-containing tumor cells. Journal of Biological Chemistry 279 23580-23589. (Pubitemid 38685672)
28. Nagy A, Armatis P, Cai RZ, Szepeshazi K, Halmos G & Schally AV 1997 Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin. PNAS 94 652-656. (Pubitemid 27053688)
29. Papac DI, Hoyes J & Tomer KB 1994 Epitope mapping of the gastrin-releasing peptide/anti-bombesin monoclonal antibody complex by proteolysis followed by matrix-assisted laser desorption ionization mass spectrometry. Protein Science 3 1485-1492. (Pubitemid 24314467)
30. Patel O, Shulkes A & Baldwin GS 2006 Gastrin-releasing peptide and cancer. Biochimica et Biophysica Acta 1766 23-41.
31. Perraut R, Lussow AR, Gavoille S, Garraud O, Matile H, Tougne C, van Embden J, van der Zee R, Lambert PH, Gysin J et al. 1993 Successful primate immunization with peptides conjugated to purified protein derivative or mycobacterial heat shock proteins in the absence of adjuvants. Clinical and Experimental Immunology 93 382-386. (Pubitemid 23276264)
32. Perschinka H, Mayr M, Millonig G, Mayerl C, van der Zee R, Morrison SG, Morrison RP, Xu Q & Wick G 2003 Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 23 1060-1065. (Pubitemid 36713561)
33. Pullen GR, Fitzgerald MG & Hosking CS 1986 Antibody avidity determination by ELISA using thiocyanate elution. Journal of Immunological Methods 86 83-87.
34. Shah JA, Darrah PA, Ambrozak DR, Turon TN, Mendez S, Kirman J, Wu CY, Glaichenhaus N & Seder RA 2003 Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice. Journal of Experimental Medicine 198 281-291. (Pubitemid 36987853)
35. Szepeshazi K, Schally AV, Nagy A, Wagner BW, Bajo AM & Halmos G 2003 Preclinical evaluation of therapeutic effects of targeted cytotoxic analogs of somatostatin and bombesin on human gastric carcinomas. Cancer 98 1401-1410. (Pubitemid 37151494)
36. Wang Y, Kelly CG, Singh M, McGowan EG, Carrara AS, Bergmeier LA & Lehner T 2002 Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70. Journal of Immunology 169 2422-2429. (Pubitemid 34920985)
37. Wang Y, Whittall T, McGowan E, Younson J, Kelly C, Bergmeier LA, Singh M & Lehner T 2005 Identification of stimulating and inhibitory epitopes within the heat shock protein 70 molecule that modulate cytokine production and maturation of dendritic cells. Journal of Immunology 174 3306-3316. (Pubitemid 40354034)
38. Xiangping Q, Dongmei X & Christian WH 2003 Biologic relevance of mammalian bombesin-like peptides and their receptors in human malignancies. Current Opinion in Endocrinology and Diabetes 10 11.
39. Xu J, Zhu Z, Wu J, Liu W, Shen X, Zhang Y, Hu Z, Zhu D, Roque RS & Liu J 2008 Immunization with a recombinant GnRH vaccine conjugated to heat shock protein 65 inhibits tumor growth in orthotopic prostate cancer mouse model. Cancer Letters 259 240-250. (Pubitemid 350251644)
40. Yankai Z, Rong Y, Yi H, Wentao L, Rongyue C, Ming Y, Taiming L, Jingjing L & Jie W 2006 Ten tandem repeats of beta-hCG 109-118 enhance immunogenicity and antitumor effects of beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65. Biochemical and Biophysical Research Communications 345 1365-1371. (Pubitemid 43817882)